A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,759 shares of CRL stock, worth $980,829. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,759
Previous 10,713 55.58%
Holding current value
$980,829
Previous $2.9 Million 66.13%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$206.39 - $268.73 $1.23 Million - $1.6 Million
-5,954 Reduced 55.58%
4,759 $983,000
Q1 2024

May 01, 2024

SELL
$203.52 - $273.43 $823,238 - $1.11 Million
-4,045 Reduced 27.41%
10,713 $2.9 Million
Q4 2023

Jan 24, 2024

SELL
$164.52 - $238.84 $104,963 - $152,379
-638 Reduced 4.14%
14,758 $3.49 Million
Q3 2023

Oct 26, 2023

SELL
$194.44 - $217.61 $718,066 - $803,633
-3,693 Reduced 19.35%
15,396 $3.02 Million
Q2 2023

Aug 10, 2023

BUY
$183.71 - $210.25 $87,997 - $100,709
479 Added 2.57%
19,089 $4.01 Million
Q1 2023

May 04, 2023

BUY
$191.89 - $259.92 $423,501 - $573,643
2,207 Added 13.45%
18,610 $3.76 Million
Q4 2022

Feb 09, 2023

BUY
$197.11 - $250.07 $812,684 - $1.03 Million
4,123 Added 33.57%
16,403 $3.57 Million
Q3 2022

Nov 10, 2022

BUY
$182.44 - $250.54 $2.24 Million - $3.08 Million
12,280 New
12,280 $2.38 Million
Q4 2021

Feb 08, 2022

SELL
$351.38 - $448.68 $602,616 - $769,486
-1,715 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$372.64 - $458.3 $204,952 - $252,065
550 Added 47.21%
1,715 $707,000
Q2 2021

Aug 11, 2021

BUY
$294.17 - $371.65 $342,708 - $432,972
1,165 New
1,165 $431,000
Q3 2019

Nov 12, 2019

SELL
$125.07 - $143.67 $1.05 Million - $1.21 Million
-8,420 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$123.4 - $148.55 $1.04 Million - $1.25 Million
8,420 New
8,420 $1.2 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.5B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.